Lifecore Biomedical Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.9% | +4.2% | +13.0% | +28.3% | +4.3% | -7.1% | -41.3% | -6.9% | -7.6% | -5.8% | -3.0% | |
| – | -7.2% | -6.0% | +19.4% | +37.1% | +18.1% | -5.6% | -16.6% | -5.7% | -30.5% | +5.7% | -4.0% | |
| – | -30.0% | -45.3% | -46.4% | -62.7% | -66.7% | +221.9% | +41.8% | -39.7% | +753.9% | -2.3% | +111.4% | |
| – | -30.0% | -45.3% | -46.4% | -62.7% | -66.7% | +221.9% | +41.8% | -39.7% | +753.9% | -2.3% | +111.4% | |
| – | -0.5% | -1.1% | +17.4% | +29.1% | +9.5% | -45.6% | +16.3% | -20.5% | -18.7% | +40.2% | -22.6% | |
| – | +2.0% | -1.0% | +25.8% | +70.1% | +22.5% | -4.9% | +6.0% | -46.1% | +11.1% | -19.2% | -9.9% | |
| – | – | – | – | – | +8.8% | -36.9% | +1.2% | -3.2% | – | – | – | |
| – | +0.0% | +10.4% | -0.5% | +40.8% | -9.6% | -51.1% | -59.1% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -62.0% | +6.6% | -4.2% | +107.2% | -15.8% | -32.7% | -39.3% | -73.0% | +0.0% | +0.0% | +0.0% | |
| – | +3.8% | -1.0% | +17.2% | +63.6% | +24.6% | -3.3% | -37.6% | -0.2% | +29.8% | -1.9% | +3.5% | |
| – | +0.6% | -9.0% | +71.8% | +55.1% | +19.9% | -38.0% | -22.2% | +122.9% | -78.0% | -22.4% | -21.9% | |
| – | +36.2% | -30.2% | +302.3% | +93.8% | +50.9% | -67.2% | +49.1% | +212.4% | -96.6% | -22.1% | -65.3% | |
| – | -11.7% | -20.6% | +41.3% | +55.7% | -4.3% | -68.4% | -3.0% | -18.0% | +26.1% | -49.7% | -29.0% | |
| – | – | – | – | – | +16.3% | +62.7% | -40.8% | +3.8% | +19.0% | +5.4% | +6.8% | |
| – | -3.5% | +7.5% | +11.5% | +7.0% | -14.5% | -12.2% | -46.8% | -18.6% | -87.1% | -88.2% | -1,163.0% | |
| – | -13.7% | +15.0% | +29.4% | +0.4% | -35.1% | -45.8% | -252.5% | – | – | – | – | |
| – | -0.7% | +1.9% | +1.0% | +2.5% | +1.9% | +0.5% | +0.7% | -0.2% | +24.4% | -5.0% | +7.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.